Anti-Malarial Drugs
Spectrophotometric detection of susceptibility to anti malarial drugs
9
Utilization of Malaria Diagnostic Tests and Receipt of Anti Malarial Drugs by Febrile Patients Attending Outpatient Clinics of Health Centre IV Facilities in Mukono District, Uganda
16
Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti malarial drugs in the Bata District (Equatorial Guinea)
10
Anti malarial drugs and the prevention of malaria in the population of malaria endemic areas
7
Psychiatric effects of malaria and anti malarial drugs: historical and modern perspectives
13
A study of toxicity and differential gene expression in murine liver following exposure to anti malarial drugs: amodiaquine and sulphadoxine pyrimethamine
10
A qualitative assessment of the challenges of WHO prequalification for anti malarial drugs in China
7
Application of the automated haematology analyzer XN 30 for discovery and development of anti malarial drugs
12
The diagnostic accuracy of the hand held Raman spectrometer for the identification of anti malarial drugs
12
Exposure to anti malarial drugs and monitoring of adverse drug reactions using toll free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance
6
Use of the atmospheric generators for capnophilic bacteria Genbag CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti malarial drugs
10
Assessing the quality of anti malarial drugs from Gabonese pharmacies using the MiniLab®: a field study
13
Prioritization of anti malarial hits from nature: chemo informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti malarial drugs
23
Evaluating harm associated with anti malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant reported adverse events and related data
9
Molecular markers in Plasmodium falciparum linked to resistance to anti malarial drugs in samples imported from Africa over an eight year period (2002 2010): impact of the introduction of artemisinin combination therapy
5
Drying anti malarial drugs in vitro tests to outsource SYBR green assays
6
Determinants of price setting decisions on anti malarial drugs at retail shops in Cambodia
12
A SYBR Green 1 based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti malarial drugs
12
Substandard anti malarial drugs in Burkina Faso
9
In vitro and in vivo combination of cepharanthine with anti malarial drugs
6